Trial Profile
A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial to Compare the Pharmacodynamic Effects of Single Doses of Insulin Detemir and Neutral Protamin Lispro (NPL) Insulin in Subjects With Type 1 Diabetes.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin neutral protamine lispro
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 01 Mar 2013 Results published in Diabetes, Obesity and Metabolism.
- 01 Oct 2009 Results presented at the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD).
- 26 Dec 2008 New trial record.